Iconic music festival Lollapalooza sets to breach a new frontier in what will be the eighth destination of the festival in Mumbai, India, bringing with it – its brand of unique, diverse and exciting flavours from the world of music. With the inaugural, first-ever edition in Asia, Lollapalooza finally brings its multi-genre music experience to Indian shores, with a world-class experience that’s never been seen before in the subcontinent.
Lollapalooza India will be a two-day musical extravaganza heldin the heart of Mumbaion January 28th-29th, 2023.
BookMyShow, India’s leading entertainment destination will spearhead Lollapalooza India as the promoter and co-producer for the festival’s Indian edition along with global producers, Perry Farrell, WME and C3 Presents.
Over three decades of pioneering and putting alternative culture on the map, Lollapaloozais a force,amongst the foremost music festivals that have been celebrated by multiple generations of fans. Founder of the festival and Jane’s Addiction frontman Perry Farrell was always ahead of the times, creating a sound for the alternative generation that came of age in the 1990s. After some great success in his early career, his band was headed for a brief hiatus with a farewell festival tour in July 1991 which soon became the global iconic platform Lollapalooza destined to change the landscape of live music forever.
31 years later, Lollapalooza is globally synonymous with alternative lifestyle, music and culture. It has travelled the world, with seven locations across three continents that annually host the event. Everyone feels at home at Lollapalooza, a festival that celebrates the culture of music, with inclusivity and unique experiences at the centre of it.
Following many years as a touring festival, Lollapalooza found its home in Chicago, U.S.A, and has grown to include annual editions across various culturally-rich countries including Chile, Brazil, Argentina, Germany, France and Sweden with more than 66 editions of the festival so far, before it comes to India in 2023.
Amongst the biggest globally, this multi-genre music festival carries the legacy of having changed the course of alternative-rock music on the global stage. From introducing genre-defining acts and artists to the world, making them household names, Lollapalooza is a melting pot of myriad genres comprising pop, rock, metal, punk rock and hip-hop as well as indie, Electronic Dance Music (EDM) and techno.
Following a philosophy of ‘Mix the music, generations, Reunite the most advanced music experts and a Neophyte public’, LollapaloozaIndiaaims to bring together music aficionados across genres, entertainment enthusiasts, global and Indian audiences that are seeking marquee, unique experiences at par with international standards. Amongst the boldest, brightest, most colourful and diverse festivals around the world, Lollapaloozais a festival that offers everyone something to take back home through its music, ethos, vibe and unparalleled experience.
The inaugural Lollapalooza Indiawill be open to over 60,000 fans each day and will be a treat for Indians and Asians all across. Featuring four stages with over 20 hours of unforgettable live music performed by some of the biggest names globally and locally, the festival is truly an experience of a lifetime with innovative culinary selections, art, fashion and much more to be witnessed in India.
Registrations for Lollapalooza India will be live on lollaindia.com starting today, July 27th until July 31st. Fans can register themselves for this musical extravaganza right now!
Be the first to get your hands on tickets for Lollapalooza India 2022 as limited Early Bird tickets for pre-registered users go live on August 1st, 2022. Early Bird tickets for Lollapalooza India’s first ever edition start Rs 7,000/- onwards. The star-studded artist line-up for the first-ever India edition of the coveted festival will be announced later this year.
Ahead of Lollapalooza’s India and Asia debut, Ashish Hemrajani, Founder & CEO, BookMyShow said, “Lollapalooza is not just a multi-genre music festival, but an alternative music experience, having driven an entire generation of alternative rock music and grunge movement into mainstream sound. Some of the biggest names like ‘Pearl Jam’, ‘Red Hot Chili Peppers’, ‘Nine Inch Nails’, ‘Rage Against The Machine’ that were brought to the world stage through their early performances at Lollapalooza, went on to make history. BookMyShow is proud to bring Lollapalooza to India – making it the 8th country and the 4th continent to do so. With a mix of some stellar Indian talent and global artists coming together on the same stage, we expect nothing short of magic.”
“The music of India is transcendental, it draws our spirits East,” said Perry Farrell, Founder, Lollapalooza, ahead of the festival’s first India edition. “Lollapalooza is an instrument for unity, peace, and education utilizing the universal languages of music and art to find common ground. You may be excited, and we are equally as excited!”
“Lollapalooza has always been about exploring boundaries, musically and geographically. We are excited to introduce Indian and Asian fans to an entirely new festival experience that has been a significant rite of passage for millions of music fans around the world for more than three decades,” said Charlie Walker, Partner, C3 Presents.
Kohler India has recently appointed Mr. Nitin Saini as Director, Supply Chain – K&B South Asia. Nitin is based out of Gurgaon responsible for accelerating transformative journey towards building a world class supply chain and enhancing the role of sourcing by using localization as a strategic and meaningful differentiator. India is a strategic market and as we embark our growth journey, excellence in customer service through digitization and competitive costs through localizing value chains.
Mr. Saini is an engineer, and a postgraduate from NITIE, Mumbai. has over 21 years of well-rounded experience spanning across verticals of Supply Chain Planning – Demand, Supply and Production, Strategic Sourcing and Logistics Management in FMCG, Food Retail and Consumer Products industries.
Mr. Saini started his career with Dabur as a Supply Chain Planner and subsequently, worked with Gillette, PepsiCo, Yum! Brands & Philips in roles of increasing leadership responsibility. He was recently associated with Delmonte India where he had end-to-end responsibility from Procurement & Planning to Order Fulfillment for the fresh and processed foods business. He played a pivotal role in leading continuous improvement in cost & service through product reengineering, value chain simplification, network optimization & digitization.
Founded in 1873 and headquartered at Kohler, Wisconsin, Kohler Co. is one of America’s oldest and largest privately held companies comprising of 40,000 associates. With more than 50 manufacturing locations worldwide, Kohler is a global leader in kitchen and bath products; engines and power systems; premier furniture, cabin, and tile; and owner/operator of two of the world’s finest five-star hospitality and golf resort destinations in Kohler, Wisconsin and St Andrews, Scotland. Kohler’s Whistling Straits golf course recently hosted the 43rd Ryder Cup. The company also develop solutions to address pressing issues, such as clean water and sanitation, for under-served communities around the world to enhance the quality of life for current and future generations.
Telugusuper news.com,Hyderabad,July30,2022: India and Princeton, NJ, USA. July 29, 2022 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced that it has entered into a licensing agreement with Princeton, New Jersey based Slayback Pharma LLC (“Slayback”), to acquire rights in Slayback’s Brimonidine Tartrate Ophthalmic Solution 0.025%, the private label equivalent of Lumify® in U.S. Lumify® is an over-the-counter (OTC) eyedrop that can be used to relieve redness of the eye due to minor eye irritations. The agreement also provides Dr. Reddy’s exclusive rights to the product outside the U.S.
Slayback Pharma is the first company to file an ANDA for the private label equivalent for Lumify® with the USFDA under Paragraph IV certification. The ANDA is currently under USFDA review and covers Brimonidine Tartrate Ophthalmic Solution 0.025% in 2.5 ml and 7.5 ml fill volumes.“We are pleased to license this important OTC ophthalmic product for the U.S. market,” says Marc Kikuchi, Chief Executive Officer, North America Generics, Dr. Reddy’s. “This product complements Dr. Reddy’s growing OTC product portfolio in the eyecare category that includes the private label versions of Pataday Once Daily Relief and Pataday® Twice Daily Relief.”
“Slayback is proud to develop this first-to-file ANDA for Lumify, a significant OTC product in the eye redness reliever category, that continues to highlight the R&D capability of the company,” said Ajay Singh, CEO and Founder of Slayback.The value of total addressable market for this product in the U.S. is approximately $130 million for the 52 weeks period ending June 12, 2022.
Westlife Development Limited (BSE: 505533) (“WDL”), owner of Hardcastle Restaurants Pvt. Ltd. (“HRPL”), the master franchisee of McDonald’s restaurants in West and SouthIndia, has announced its financial results for the quarter ended June 30, 2022.
Westlife now has a total of331 restaurants across 48 cities as of June 2022 with 65 Drive-Thrus, 267 McCafés and 132 Experience of the Future (EOTF) restaurants.
* Extraordinary Expenses includes one-time expenses on account of assets written-off pertaining to restaurants relocation/closure and a onetime ESOP charge (Refer to Note 1 in financial results for further details)
The company witnessed a solid start to the first quarter of FY23 and recorded an all-time-high sales figure of Rs. 5,379million, which is a strong jump of 108% Y-o-Y. Westlife witnessed strong performances for three quarters in a row with more than Rs. 60 million of Average Annualized Sales per store and over 16% EBITDA margin led by Menu innovations andOmni channel strategy. It posted a cash PAT of over Rs.551 million. The same store sales growth (SSG) saw a significant increase of 97% Y-o-Y
The follow-through of the topline growth also gave WDL’s margins a strong boost as it recordedRestaurant Operating Margins (ROM)of 21.6% which is 4.5 times last year, a 68% jump from Q1 FY20. Operating EBITDA margins stood at 17.1% while the CashPAT margin was 10.2%. The company grew 41% over pre-Covid base of Q1FY20. More than 55% of the overall business growth came through digital channels. Westlife also witnessed highest quarterly sales on McDelivery Appwith over 18.5 million cumulative downloads.
On store expansion, 5 restaurants were added during the quarter with 12 restaurants in ground-break.Westlife plans to add 35-40 new restaurants in FY23 and over 200 new restaurants in the next 3-4 years with greater emphasis onsmaller and emerging cities.The company’s growth in both dine-in and convenience channels has been continually setting a new baseline for the business. While Dine-in grew five times from the last year, the growth in Convenience remains healthy at 13% YoY.
Mr. Amit Jatia, Vice-Chairman of Westlife Development Limited, said,“Ourbusiness performancein the lastthree quarters is a testament to the robust strategy we have been following as well as the trust and lovewe have managed to buildfor our iconic brand.We are proud to report our strong performance which reinforces the strength and resilience of our company. We have been making meaningful progress quarter on quarter against every strategic growth pillar of our omnichannel business, menu innovations, and store expansion plans.With a redefined cost structure, increased productivity, strong average unit volumes, and healthy restaurant cash flows, we are well-positioned to deliver accelerated business results and create long-term value for shareholders”.
While Westlife’smenu innovation strategy has madethe brand a leader in the snacking categoryin the West, with additionslike the Gourmet Burger range and McSpicy Fried Chicken in its South market, the company is strengthening its Meals proposition.With the inclusion of McSpicy Fried Chicken to its menu at its restaurants in South India, the company has entered the Rs. 5,000 crore chicken marketin the South and is working towards acquiring market leadership.
Some stories leave an indelible impression on our minds and keep us yearning for more. One such story is SonyLIV’s Maharani, which had the audience on the edge of their seats with its gripping narrative. Centred around a female lead who navigates the patriarchal hurdles in society to emerge as a formidable political face, the season finale left viewers pining for more. Putting an end to the audience’s wait, the show is back with an exciting season 2 with Neha Chauhan and Anuja Sathe joining ensemble cast.
Neha Chauhan will be seen playing the role of Kalpana Kaul – a suave and ambitious woman, running her own political consultancy firm called I-ACT. Talking about her role, Neha said, “I have been a big fan of the show since the first season, so it feels great to join such a stellar cast and work with the wonderful Subhash Kapoor Sir. My character will take things up a notch and catalyse plot twists that will unfold this season. I have never done anything like this before and am excited to see the audience’s reaction.”
Stepping into the shoes of a political candidate, Anuja Sathe portrays Kirti Singh, who becomes Bheema Bharti’s (Sohum Shah) confidante. Commenting on her role, she said, “I have always been very lucky when it comes to roles. Keeping the trend alive, the audience will see me in a new avatar in this show. Kirti is totally opposite to how I am in real life, so it was an exciting and fulfilling experience for me as an actor. I had to be convincing while portraying the various shades of my character. The entire cast and crew have been very supportive, and I had a great time working with all of them.”
Maharani 2 is directed by Ravindra Gautam, with Subhash Kapoor and Nandan Singh serving as showrunners and writers of the show. Headlined by Huma Qureshi, the show also features, Sohum Shah, Amit Sial, Vineet Kumar, Inaamulhaq, Dibyendu Bhattacharya, Kani Kasturi, Pramod Pathak and Vineet Kumar in prominent roles.
Telugu super news.com,Bengaluru,July29th,2022: When it comes to biryani, it is safe to say that for Indians it is not just a dish but an emotion. Bringing people together for years, biryani has become an expression of love and bonding amongst friends and families. Everybody loves a scrumptious plate of biryani filled with aromatic rice, tantalizing flavors of spices, and most importantly, the juicy succulent meat.
Everyone knows that the best biryani is the one that is made at home. With love, care & many hours of patience, perseverance, and skillful cooking. The privilege of home-made biryani might have been rare in the past, but Licious is here to change that game. Licious, India’s much loved fresh meats & seafood brand & the country’s first D2C unicorn, is well known for shifting the paradigm when it comes to curating delectable meaty products, that are of the highest quality & freshness. With the launch of its Biryani Meat and Masala Mix range, Licious is all set to repeat this history.
The brand has introduced five variants in three popular lip-smacking biryani flavours -Hyderabadi, Awadhi, and Kolkata, in a form of easy-to-use mixes. Foraying into the full-meal category, Licious announced the expansion of its ready-to-cook range with their biryani mix box that comes with pre-cooked, marinated chicken and biryani seasoning, which allows consumers to cook the dish in just three easy steps. As quality experts, the brand has consciously made the biryani mix meatier with its fresh premium cuts.
Speaking about the launch, Nichelle Kamat, VP- Category, Licious, said, “Biryani is an iconic delicacy, and undoubtedly one of the most popular dishes in India. While everyone loves eating Biryani, the elaborate cooking process of it is exhausting.This is where Licious’s Biryani Meat and Masala Mix comes in! Our expertise & nuanced consumer insights have helped us create an easy ready-to-cook biryani mix. It is a perfect blend of meat and spices, which will help our consumers prepare biryani in just three steps in their own kitchens. We have also ensured that our consumers have choices, hence we have launched our biryani mix in three of the most popular flavors.”
She adds, “As a brand, we have proactively worked towards adding convenience into our customer’s life. Over the last few years, we have launched multiple ready-to-cook & eat products in mutton, chicken, fish, and prawn categories. With biryani mix, we have taken our first step towards the wholesome meal category, and we are looking forward to innovating more such products.”
The campaign announcing the launch, takes a cheeky dig at the painstaking cooking process of biryani ending with an unsatisfactory outcome. It encapsulates the struggle of finding actual meat in biryani, often faced by meat lovers while ordering the dish from restaurants. As a part of the campaign, Licious has launched a digital ad campaign on their social media platforms. The first film captures a lover’s romantic gesture of cooking biryani for his partner gone terribly wrong. The second ad film depicts the banter, shared among friends in quest of the meaty pieces in a biryani. Created by Licious’ in-house creative team, the ads ride on the sentiments associated with the beloved delicacy of biryani. It presents Licious’ biryani as the perfect solution for tasty biryani at home.
The new digital ads are LIVE on all social media platforms. It will be further amplified through Licious’ digital assets. Licious will also roll-out an extensive print campaign along with a prominent presence across modern trade and e-com sites.Since its inception in 2015, Licious has adopted 100% traceable and sustainable sourcing practices, creating quality benchmarks for the industry.
The Bangalore-based brand is also the largest D2C brand from India to be certified with FSSC22000, one of the highest food safety certifications in the world. Rooted in a sustainability mission, Licious is also the first company in the segment to take a pledge towards achieving complete ESG compliance. Starting at Rs 399, Licious Biryani mix is available in regular and small sizes. At present, it can be ordered from Licious’ website in Mumbai, Bangalore, Chennai, Delhi and Kolkata. Ad links: Mutton variant: https://youtu.be/Xrr5ifU2R34 Chicken variant: https://youtu.be/jPvKBCtNdFQ
Telugu super news.com,Hyderabad, July29th,2022: Samsung Electronics announced that it will unveil the next generation of its foldable smartphones on August 10, 2022. Samsung has been pushing boundaries, defying conventions and opening doors to new experiences. Meangingful innovations go beyond the technical and provide a platfrom upon which our everyday lives become richer and more versatile.
Join us to unlock new experiences that transform our lives for the better and open us up to greater possibilities than ever before. Galaxy Unpacked will take place on August 10, 2022 and will be livestreamed on Samsung Newsroom India starting 6:30pm IST. Stay tuned to Samsung Newsroom for regular updates ahead of the event.
Telugu super news.com,Hyderabad, July29th,2022:Prime Day 2022 in India came to a successful close this weekend (July 23 and 24) with members across India discovering joy at the two-day celebration with the best deals, savings, new launches, blockbuster entertainment and more! Prime members from 95% of the pin codes in India purchased during this year’s Prime Day more than 32,000 sellers saw their highest ever sales day.
1.5x more customers signed up for Prime membership compared to last year’s Prime Day, with 2 out of 3 new members joining from outside of Top 10 town/cities like Rourkela, Mokokchung, Kullu, Dholpur, Nagapattinam, Tonk, Sehore, Kanchipuram, Raebareli, Ramgarh, Thanjavur, Sawai Madhopur, Yamuna Nagar. India’s Prime Day entertainment line-up on Prime Video was loved by consumers within and outside the country. Prime members from over 3800 Indian cities and towns, and in over 230 countries and territories have watched India’s Prime Day releases on Prime Video.
Commenting on the success of the event, Akshay Sahi, Director, Prime and Delivery Experience, Amazon India said,“Prime Day is a celebration of our Prime members; Small & medium businesses and we are truly humbled by their participation. We had thousands of deals, 500+ new product launches from brand partners and sellers and exciting blockbuster entertainment which our customers loved. The strong growth of new Prime member sign-up especially from smaller towns and cities across India is a strong testament to Amazon Prime’s commitment to provide unmatched value to our members, every day.”
Customers shopped from 50% more seller’s vs last Prime Day, from 11,738 pincodes during the lead up and on Prime Day this year. 70% of the sellers who received an order are from Tier 2-3-4 cities like Kolhapur, Surat, Ghaziabad, Raipur, Coimbatore, Mangalore, Jalandhar and Cuttack. These sellers include artisans, weavers, women entrepreneurs, start-ups and brands, local offline neighbourhood stores. More than 32,000 sellers saw their highest ever sales day. Nearly 18% more sellers’ grossed sales over INR 1 crore and close to 38% more sellers grossed sales of over 1 lakh vs last Prime Day. Local neighbourhood shops that sell on Amazon.in witnessed a sales growth of 4X. Customers enthusiastically chose to buy genuine Indian handlooms and handicrafts as artisans, weavers and artisanal brands from Amazon Karigar witnessed nearly 4.5X sales uplift. Women Entrepreneurs under the Amazon Saheli doubled their sales.
Telugusupernews.com,Hyderabad, India, July 29, 2022: Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY |NYSE: RDY | NSEIFSC: DRREDDY) today announced its consolidated financial results for the quarter ended June 30, 2022. The information mentioned in this release is on the basis of consolidated financial statements under International Financial Reporting Standards (IFRS).
Commenting on the results, Co-Chairman & MD, G V Prasad said “Our underlying business revenues adjusted for covid products contribution during last year have grown well. The profits were aided by a few non-recurring incomes, offsetting the near term headwinds. We continue to improve the health of our core businesses through productivity improvement and robust product pipelines”. Revenues Gross Margin
Revenue Mix by Segment Segment Q1 FY23 Q1 FY22 YoY Gr %
Q4 FY22 QoQ Gr % (Rs.) (Rs.) (Rs.) Global Generics 44,324 41,113 8 46,118 (4) North America 17,815 17,390 2 19,971 (11) Europe 4,141 3,994 4 4,444 (7) India 13,339 10,600 26 9,689 38 Emerging Markets 9,028 9,129 (1) 12,013 (25) Pharmaceutical Services and Active Ingredients (PSAI) 7,090 7,540 (6) 7,557 (6) Others 740 541 37 693 7 Total 52,154 49,194 6 54,368 (4)
34%
8%
26% 17% 14% 1% Q1 FY23 Sales Mix
North America Europe India Emerging Markets PSAI Others
4
Revenue Analysis Global Generics (GG) Revenues from GG segment at Rs. 44.3 billion: Year-on-year growth of 8% was driven by new product launches across most of our businesses and divestment of a few non-core brands in India, partly offset by price erosion in our generic markets, and higher base due to covid product sales in previous year. Sequential decline of 4% was due to sales decline in North America (incremental competition on key products and price erosion) and Emerging Markets (normalization of channel inventory in Russia). This was partly offset by new product launches. North America Revenues from North America at Rs. 17.8 billion: Year-on-year growth of 2%, driven by launch of new products and favorable forex rates, which was offset by price erosion in some of our key molecules. Sequential decline of 11% was primarily on account of price erosion and decline in volumes for few products due to incremental competition. During this quarter, we launched 7 new products. This includes launch of Ketorolac, OTC Nicotine Lozenges Original, Methylprednisolone Sodium Succinate, Pemetrexed Injection, Posaconazole Tabs and Sorafenib in the US and Pemetrexed Inj. in Canada. We filed three ANDAs during the quarter. As of 30 th June 2022, cumulatively 86 generic filings are pending for approval with the USFDA (83 ANDAs and 3 NDAs under 505(b)(2) route). Out of these 86 pending filings, 44 are Para IVs and we believe 24 have ‘First to File’ status. Europe Revenues from Europe at Rs. 4.1 billion: Year-on-year growth of 4%, driven by launch of new products and scale up of base business, which was partly offset by price erosion in some molecules and adverse forex rates during the quarter. Sequential decline of 7% was primarily on account of price erosion and adverse forex rates, which was partly offset by volume traction in base business. India Revenues from India at Rs. 13.3 billion: Year-on-year growth of 26% was driven by divestment of a few non-core brands, revenue contribution from the products acquired / in-licensed from Novartis, growth in base business and new products contribution. The growth was partially offset due to covid product sales in Q1 FY22 which was not there in the current quarter.
5 Sequential growth of 38% was primarily driven by divestment of a few non-core brands, revenue contribution from the products acquired / in-licensed from Novartis, new products contribution and growth in base business. We launched five new products during the quarter. Emerging Markets Revenues from Emerging Markets at Rs. 9.0 billion. Year-on-year decline of 1% and sequential decline of 25%: Revenues for Russia at Rs. 3.2 billion. Year-on-year decline of 9% is primarily due to channel inventory normalization post stocking up in Q4 FY22, which was partly offset with launch of new products. Sequential decline of 53% was due to higher base in Q4 FY22 from brand divestment income and channel inventory normalization in the current quarter. Revenues from other CIS countries and Romania at Rs. 1.9 billion. Year-on-year growth of 33% driven by volume traction in base business, favorable price benefits in some of our products and launch of new products. Sequential decline of 16% was primarily on account of reduction in volumes. Revenues from Rest of World (RoW) territories at Rs. 3.9 billion. Year-on-year decline of 6% primarily on account of higher base in Q1 FY22 due to covid product sales and price decline in current quarter, partly offset by new product launches. Sequential growth of 36% was largely attributable to volume traction in our base business, price benefits in some of our markets and launch of new products. Pharmaceutical Services and Active Ingredients (PSAI) Revenues from PSAI at Rs. 7.1 billion. Year-on-year and sequential decline of 6% each. Year-on-year decline was primarily on account of higher base in Q1 FY22 with covid product sales, partly offset by new products launched and favorable forex rates. Sequential decline was primarily due to lower volumes of base business, partly offset by new product launches.
6
Income Statement Highlights: Gross profit margin at 49.9%:
Decreased by ~230 bps over previous year and by ~300 bps sequentially, primarily on account of higher commodity prices, adverse leverage on manufacturing overheads, price erosion and forex related impact, which was partially benefited from brand divestment income.
Gross profit margin for GG and PSAI business segments are at 55.0% and 15.7% respectively. Selling, general & administrative (SG&A) expenses at Rs. 15.5 billion, increased by 3% on a year- on-year basis and declined by 1% sequentially. Year-on-year increase was primarily attributable to investments being done towards marketing of some of our key brands, investments in digitalization and annual increments, which was partially offset with lower legal and professional expenses. On sequential basis, the expenses have been largely flat. Research & development (R&D) expenses at Rs. 4.3 billion. As % to revenues – Q1 FY23: 8.3% | Q4 FY22: 8.0% | Q1 FY22: 9.2%. Our focus continues on building a global pipeline of products across our markets. Other operating income at Rs. 6.0 billion compared to Rs. 0.5 billion in Q1 FY22. The increase was mainly on account of recognition of income from settlement agreement, with Indivior Inc., Indivior UK Limited and Aquestive Therapeutics, Inc., resolving all claims between the parties relating to the generic buprenorphine and naloxone sublingual film. Net Finance income at Rs. 2.3 billion compared to Rs. 0.7 billion in Q1 FY22. The increase was primarily on account of foreign exchange gains due to favorable ruble rates. Profit before Tax at Rs. 14.7 billion, increased by 97% year-on-year and increased by 490% sequentially. Profit after Tax at Rs. 11.9 billion. The effective tax rate is 19.0% for the quarter. Diluted earnings per share is at Rs. 71.40. Other Highlights: EBITDA is at Rs. 17.8 billion and the EBITDA margin is 34.1%. Capital expenditure is at Rs. 3.3 billion. Free cash-flow is a net outflow of Rs. 2.3 billion. Net cash surplus for the company is at Rs. 12.8 billion as on June 30, 2022. Consequently, net debt to equity ratio is (0.06).
7 Earnings Call Details (06:30 pm IST, 09:00 am EDT, July 28, 2022) The management of the Company will host an earnings call to discuss the Company’s financial performance and answer any questions from the participants. Conference Joining Information Option 1: Express Join with DiamondPass™ Pre-register with the below link and join without waiting for the operator. https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=3962534&linkSecurityString=119134f0e6 Option 2: Join through below Dial-In Numbers Universal Access Number: +91 22 6280 1219 +91 22 7115 8120
No password/pin number is necessary to dial in to any of the above numbers. The operator will provide instructions on asking questions before and during the call. Play Back: The play back will be available after the earnings call, till August 3 rd , 2022. For play back dial in phone No: +91 22 7194 5757 | +91 22 6663 5757, and Playback Code is 96436. Transcript: Transcript of the Earnings call will be available on the Company’s
